Conversation with The Cancer Letter Letai: Perceptions aside, money is flowing and the cancer research infrastructure is sturdyNCI expects record-breaking spending on extramural research April 10, 2026Vol.52 No.14By Claire Marie Porter and Paul Goldberg
Guest Editorial America needs a new blueprint for the National Cancer ProgramFirst step: Develop Version 2.0 of Paul Calabresi’s “Cancer at a Crossroads” April 10, 2026Vol.52 No.14By Robert A. Winn
California state-funded institute scraps selection process that put cancer projects at a disadvantageCancer researchers are resubmitting applications to the California Institute for Regenerative Medicine April 10, 2026Vol.52 No.14By Sara Willa Ernst
Trials & Tribulations Protecting the cure: Why the future of radiation oncology must be precision-guided April 10, 2026Vol.52 No.14By J. Isabelle Choi
News Analysis HHS presents new protein-forward dietary guidelines, turning the food pyramid upside downThe Kennedy guidelines are mum on cancer risks associated with red meat and alcohol April 03, 2026Vol.52 No.13By Claire Marie Porter
Free Ukrainian oncologists press on in year four of wartime disruptionsAmid missiles and blackouts, “you cannot put your life on a pause forever.” April 03, 2026Vol.52 No.13By Sara Willa Ernst
FreeGuest Editorial FDA’s guidance on MRD in MM goes beyond the ODAC vote—and that’s where it matters mostDraft guidance consolidates trial design updates for developers April 03, 2026Vol.52 No.13By Nicholas Richardson
Editorial The Cancer Letter Podcast nominated for 30th annual Webby Awards April 03, 2026Vol.52 No.13By Paul Goldberg and Jacquelyn Cobb
PodcastThe Directors The Directors: Wistar’s Altieri and ChristianaCare’s Petrelli say partnership of their institutions will go on as the guard changes March 27, 2026Vol.52 No.12By Sara Willa Ernst and Paul Goldberg
FreeTrials & Tribulations Early-onset cancer is on the rise. Here is how OSUCCC–James is adapting to the needs of younger patients March 27, 2026Vol.52 No.12By W. Kimryn Rathmell
